Position in KALV
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$4,569,328
+$746,785 QoQ
Shares Held
226,991
-4.1% QoQ
Ownership
0.426%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#48
of 182 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026F/m Investments LLC holds $71,155,293 across 22 Biotechnology names. KALV ranks #6 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17,384 | $13,431,573 | |
| 2 | COGT |
Cogent Biosciences, Inc.
|
226,142 | $8,704,205 | |
| 3 | SYRE |
Spyre Therapeutics, Inc.
|
99,460 | $5,016,762 | |
| 4 | TVTX |
Travere Therapeutics, Inc.
|
164,990 | $4,901,852 | |
| 5 | MIRM |
Mirum Pharmaceuticals, Inc.
|
50,911 | $4,703,158 | |
| 6 | KALV |
KalVista Pharmaceuticals, Inc.
This page
|
226,991 | $4,569,328 | |
| 7 | NKTR |
Nektar Therapeutics
|
61,104 | $4,396,432 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
54,599 | $4,054,521 |
All Filings in KALV
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,569,328 | 226,991 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $3,822,543 | 236,690 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $2,426,304 | 199,204 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,060,471 | 182,262 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $578,119 | 50,097 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||